The next direction for Alzheimer's disease treatments
Interviewee/Contributor
Jean-Claude Muller
Organisation
MedNous
Research Directory
A new start for an amyloidosis therapy
Interviewee/ContributorPierre VandepapelièreOrganisationAmyl Therapeutics BVThe RECOVERY trial - what has been achieved so far?
Interviewee/ContributorPeter CharlishOrganisationMedNousStock market performance: Tobacco reinvents itself
Interviewee/ContributorVictoria EnglishOrganisationMedNousA new paradigm for gene therapy
Interviewee/ContributorPeter MarksOrganisationUS Food and Drug AdministrationNovel antifungals set for market introduction
Interviewee/ContributorPeter CharlishOrganisationMedNousLive biotherapeutics change the pharma landscape
Interviewee/ContributorDuncan PeytonOrganisation4D pharma PlcASCO 2021- Oncology developers disclose their latest data
Interviewee/ContributorVictoria EnglishOrganisationMedNousPharma invests in R&D across a broad front
Interviewee/ContributorVictoria English and Jean-Claude MullerOrganisationMedNousOncology approvals rise, driven by novel compounds
Interviewee/ContributorBruno PagliaraOrganisationMedNous